908 related articles for article (PubMed ID: 8784462)
1. p53 alterations in chemically induced hamster cheek-pouch lesions.
Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E
Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462
[TBL] [Abstract][Full Text] [Related]
2. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D
Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024
[TBL] [Abstract][Full Text] [Related]
3. Expression of survivin and XIAP for DMBA-induced hamster buccal pouch squamous cell carcinogenesis is associated with p53 accumulation.
Hsue SS; Chen YK; Lin LM
Oral Oncol; 2008 Jan; 44(1):43-9. PubMed ID: 17306609
[TBL] [Abstract][Full Text] [Related]
4. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
[TBL] [Abstract][Full Text] [Related]
5. Changes in keratin expression during 7,12-dimethylbenz[a]anthracene-induced hamster cheek pouch carcinogenesis.
Gimenez-Conti IB; Shin DM; Bianchi AB; Roop DR; Hong WK; Conti CJ; Slaga TJ
Cancer Res; 1990 Jul; 50(14):4441-5. PubMed ID: 1694722
[TBL] [Abstract][Full Text] [Related]
6. Survivin expression is regulated by an epigenetic mechanism for DMBA-induced hamster buccal-pouch squamous-cell carcinomas.
Chen YK; Hsue SS; Lin LM
Arch Oral Biol; 2005 Jun; 50(6):593-8. PubMed ID: 15848153
[TBL] [Abstract][Full Text] [Related]
7. p53 and Ha-ras mutations in chemically induced hamster buccal pouch carcinomas.
Chang KW; Lin SC; Koos S; Pather K; Solt D
Carcinogenesis; 1996 Mar; 17(3):595-600. PubMed ID: 8631150
[TBL] [Abstract][Full Text] [Related]
8. Correlation between inducible nitric oxide synthase and p53 expression for DMBA-induced hamster buccal-pouch carcinomas.
Chen YK; Hsue SS; Lin LM
Oral Dis; 2003 Sep; 9(5):227-34. PubMed ID: 14628889
[TBL] [Abstract][Full Text] [Related]
9. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
[TBL] [Abstract][Full Text] [Related]
10. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data.
O'Malley FP; Vnencak-Jones CL; Dupont WD; Parl F; Manning S; Page DL
Lab Invest; 1994 Jul; 71(1):67-72. PubMed ID: 8041120
[TBL] [Abstract][Full Text] [Related]
11. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
[TBL] [Abstract][Full Text] [Related]
12. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H
Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937
[TBL] [Abstract][Full Text] [Related]
13. High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay.
Kashiwazaki H; Tonoki H; Tada M; Chiba I; Shindoh M; Totsuka Y; Iggo R; Moriuchi T
Oncogene; 1997 Nov; 15(22):2667-74. PubMed ID: 9400993
[TBL] [Abstract][Full Text] [Related]
14. Chronic ultraviolet exposure-induced p53 gene alterations in Sencar mouse skin carcinogenesis model.
Tong Y; Smith MA; Tucker SB
J Toxicol Environ Health; 1997 Jun; 51(3):219-34. PubMed ID: 9183379
[TBL] [Abstract][Full Text] [Related]
15. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis.
Bennett WP; Hollstein MC; Metcalf RA; Welsh JA; He A; Zhu SM; Kusters I; Resau JH; Trump BF; Lane DP
Cancer Res; 1992 Nov; 52(21):6092-7. PubMed ID: 1394236
[TBL] [Abstract][Full Text] [Related]
16. Characterization of p53 gene mutations in a Brazilian population with oral squamous cell carcinomas.
Chaves AC; Cherubini K; Herter N; Furian R; Santos DS; Squier C; Domann FE
Int J Oncol; 2004 Feb; 24(2):295-303. PubMed ID: 14719105
[TBL] [Abstract][Full Text] [Related]
17. Genomic p53 mutation in a chemically induced hamster pancreatic ductal adenocarcinoma.
Chang KW; Mangold KA; Hubchak S; Laconi S; Scarpelli DG
Cancer Res; 1994 Jul; 54(14):3878-83. PubMed ID: 8033110
[TBL] [Abstract][Full Text] [Related]
18. p53 alterations but no human papillomavirus infection in preinvasive and advanced squamous esophageal cancer in Italy.
Rugge M; Bovo D; Busatto G; Parenti AR; Fawzy S; Guido M; Ancona E; Ninfo V; Ruol A; Shiao YH
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):171-6. PubMed ID: 9138659
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
20. Cloning of hamster osteopontin and expression distribution in normal tissues and experimentally induced oral squamous-cell carcinoma.
Jin H; Valverde P; Chen J
Arch Oral Biol; 2006 Mar; 51(3):236-45. PubMed ID: 16095557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]